Is Chronic Breathlessness Less Recognised and Treated Compared with Chronic Pain? A Case-based Randomised Controlled Trial

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2018 Jul 14

PMID 30002106

Citations 24

Authors

Zainab Ahmadi

Jacob Sandberg

Aaron Shannon-Honson

Zac Vandersman

David C Currow

Magnus Ekstrom

Affiliations

Soon will be listed here.

Citing Articles

Translation and Linguistic Validation of the Multidimensional Dyspnoea Profile into Telugu in a Palliative Care Setting.

Dufberg L, Kokritz M, Palat G, Ekstrom M, Brun E, Segerlantz M Indian J Palliat Care. 2025; 31(1):48-51.

PMID: 40027971 PMC: 11866661. DOI: 10.25259/IJPC_244_2024.

Differences in uni-dimensional breathlessness measures and thresholds for clinical response in a randomised controlled trial in people with chronic breathlessness: an exploratory study.

Ferreira D, Ekstrom M, Louw S, McCloud P, Johnson M, Clark K BMJ Open Respir Res. 2024; 11(1.

PMID: 39632100 PMC: 11624816. DOI: 10.1136/bmjresp-2024-002370.

Empathetic solicitude attenuates the affective and sensory dimensions of CO-induced dyspnea: A randomized parallel arm experimental trial in healthy humans.

Nion N, Nierat M, Lavault S, Simon-Tillaux N, Guerder A, Blanchard P Psychophysiology. 2024; 62(2):e14740.

PMID: 39627961 PMC: 11870812. DOI: 10.1111/psyp.14740.

Multicomponent services for symptoms in serious respiratory illness: a systematic review and meta-analysis.

Spathis A, Reilly C, Bausewein C, Reinke L, Romero L, Smallwood N Eur Respir Rev. 2024; 33(174).

PMID: 39477352 PMC: 11522971. DOI: 10.1183/16000617.0054-2024.

Translation and Linguistic Validation of the Multidimensional Dyspnea Profile into Hindi in a Palliative Care Setting.

Kokeritz M, Dufberg L, Palat G, Ekstrom M, Brun E, Segerlantz M Indian J Palliat Care. 2024; 30(3):252-259.

PMID: 39371501 PMC: 11450885. DOI: 10.25259/IJPC_46_2024.

References

Basoglu M . Effective management of breathlessness: a review of potential human rights issues. Eur Respir J. 2017; 49(5). DOI: 10.1183/13993003.02099-2016. View

Mularski R, Campbell M, Asch S, Reeve B, Basch E, Maxwell T . A review of quality of care evaluation for the palliation of dyspnea. Am J Respir Crit Care Med. 2010; 181(6):534-8. DOI: 10.1164/rccm.200903-0462PP. View

Ekstrom M, Abernethy A, Currow D . The management of chronic breathlessness in patients with advanced and terminal illness. BMJ. 2015; 350:g7617. DOI: 10.1136/bmj.g7617. View

Ekstrom M, Nilsson F, Abernethy A, Currow D . Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc. 2015; 12(7):1079-92. DOI: 10.1513/AnnalsATS.201501-034OC. View

Sundh J, Ekstrom M . Persistent disabling breathlessness in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016; 11:2805-2812. PMC: 5108478. DOI: 10.2147/COPD.S119992. View

Lohman D, Schleifer R, Amon J . Access to pain treatment as a human right. BMC Med. 2010; 8:8. PMC: 2823656. DOI: 10.1186/1741-7015-8-8. View

Ahmadi Z, Bernelid E, Currow D, Ekstrom M . Prescription of opioids for breathlessness in end-stage COPD: a national population-based study. Int J Chron Obstruct Pulmon Dis. 2016; 11:2651-2657. PMC: 5085299. DOI: 10.2147/COPD.S112484. View

Johnson M, Yorke J, Hansen-Flaschen J, Lansing R, Ekstrom M, Similowski T . Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J. 2017; 49(5). DOI: 10.1183/13993003.02277-2016. View

Young J, Donahue M, Farquhar M, Simpson C, Rocker G . Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists. Can Fam Physician. 2012; 58(7):e401-7. PMC: 3395547. View

10.

Verberkt C, van den Beuken-van Everdingen M, Schols J, Datla S, Dirksen C, Johnson M . Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis. Eur Respir J. 2017; 50(5). DOI: 10.1183/13993003.01153-2017. View

11.

Janssen D, de Hosson S, Bij de Vaate E, Mooren K, Baas A . Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians. Chron Respir Dis. 2015; 12(2):85-92. DOI: 10.1177/1479972315571926. View

12.

Rocker G, Young J, Donahue M, Farquhar M, Simpson C . Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. CMAJ. 2012; 184(9):E497-504. PMC: 3381775. DOI: 10.1503/cmaj.111758. View

13.

Currow D, Abernethy A, Ko D . The active identification and management of chronic refractory breathlessness is a human right. Thorax. 2013; 69(4):393-4. DOI: 10.1136/thoraxjnl-2013-204701. View